MS-R001

· Santen Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MS-R001, covering 2010-07-26 to 2010-07-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy [Phase 1]

See pricing